Soc. Generale Knock-Out BIO/ DE000SW1ZZ26 /
2024-10-18 9:43:40 PM | Chg.+0.310 | Bid9:59:20 PM | Ask9:59:20 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
24.830EUR | +1.26% | 24.920 Bid Size: 2,000 |
25.200 Ask Size: 2,000 |
Bio Rad Laboratories... | 73.96 USD | 2078-12-31 | Call |
GlobeNewswire
08-12
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
06-24
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
06-03
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
2022-03-29
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
2022-03-22
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
2021-08-03
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
2021-06-01
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
2020-08-24
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
2020-05-04
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
2020-04-16
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
2020-03-20
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
2020-03-09
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com